A detailed history of Exeter Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exeter Financial, LLC holds 4,396 shares of BMY stock, worth $174,345. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,396
Previous 5,154 14.71%
Holding current value
$174,345
Previous $264,000 9.85%
% of portfolio
0.11%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $36,368 - $41,235
-758 Reduced 14.71%
4,396 $238,000
Q4 2023

Jan 16, 2024

SELL
$48.48 - $57.85 $2,133 - $2,545
-44 Reduced 0.85%
5,154 $264,000
Q2 2023

Jul 27, 2023

SELL
$63.71 - $70.74 $3,185 - $3,536
-50 Reduced 0.95%
5,198 $332,000
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $3,285 - $3,726
50 Added 0.96%
5,248 $363,000
Q3 2022

Oct 13, 2022

SELL
$0.13 - $76.84 $1 - $998
-13 Reduced 0.25%
5,198 $370,000
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $10,747 - $11,837
-148 Reduced 2.76%
5,211 $401,000
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $24,469 - $29,340
398 Added 8.02%
5,359 $391,000
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $3,095 - $3,371
-50 Reduced 1.0%
4,961 $332,000
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $23,736 - $26,695
400 Added 8.67%
5,011 $316,000
Q2 2020

Jul 21, 2020

SELL
$54.82 - $64.09 $38,812 - $45,375
-708 Reduced 13.31%
4,611 $271,000
Q1 2020

Apr 23, 2020

BUY
$46.4 - $67.43 $51,411 - $74,712
1,108 Added 26.31%
5,319 $296,000
Q4 2019

Jan 29, 2020

SELL
$49.21 - $64.19 $46,651 - $60,852
-948 Reduced 18.38%
4,211 $270,000
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $3,635 - $4,310
85 Added 1.68%
5,159 $262,000
Q2 2019

Jul 26, 2019

SELL
$44.62 - $49.34 $5,309 - $5,871
-119 Reduced 2.29%
5,074 $230,000
Q1 2019

Apr 09, 2019

BUY
$45.12 - $53.8 $234,308 - $279,383
5,193 New
5,193 $248,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Exeter Financial, LLC Portfolio

Follow Exeter Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exeter Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exeter Financial, LLC with notifications on news.